Long-term treatment outcome and mutational analysis of patients on third-line antiretroviral therapy in programmatic conditions.
Jaya ChakravartyShweta SrivastvaAnurag Kumar KushwahaArijit PalPublished in: The Journal of antimicrobial chemotherapy (2023)
This study demonstrates good long-term outcome in patients on standardized third-line ART in programmatic conditions with very few mutations in those failing the therapy.
Keyphrases
- antiretroviral therapy
- end stage renal disease
- hiv infected
- chronic kidney disease
- newly diagnosed
- ejection fraction
- human immunodeficiency virus
- hiv aids
- hiv positive
- prognostic factors
- hiv infected patients
- peritoneal dialysis
- mesenchymal stem cells
- south africa
- bone marrow
- patient reported outcomes
- men who have sex with men
- hepatitis c virus
- cell therapy
- patient reported